Skip to main content
رجوع
Watch Compare

Citius Pharmaceuticals, Inc.

جودة البيانات: 83%
CTXR
Nasdaq Manufacturing Chemicals
KWD 0.84
▲ KWD 0.01 (1.49%)
القيمة السوقية: 18.85 M
السعر
KWD 0.84
القيمة السوقية
18.85 M
نطاق اليوم
KWD 0.80 — KWD 0.87
نطاق 52 أسبوعًا
KWD 0.63 — KWD 2.48
حجم التداول
232,499
فتح KWD 0.82
متوسط 50 يوم / 200 يوم
KWD 0.79
6.43% above
متوسط 50 يوم / 200 يوم
KWD 1.16
27.08% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -34.84 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-53.58%
أقل من متوسط القطاع (-51.02%)
ROIC-33.29%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.99
Interest Coverage-182.70

التقييم

PE (TTM)
-0.49
أعلى من متوسط القطاع (-1.98)
P/B Ratio0.24
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -0.5 -2.0
P/B 0.2 5.1
ROE % -53.6 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -38.85 M
ROE -53.58% ROA -28.99%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -34.84 M
ROIC -33.29% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.99
Interest Coverage -182.70 Asset Turnover N/A
Working Capital -261,987 Tangible Book Value 70.61 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.49 Forward P/E N/A
P/B Ratio 0.24 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -184.83%
Market Cap 18.85 M Enterprise Value 11.13 M
Per Share
EPS (Diluted TTM) -2.46 Revenue / Share N/A
FCF / Share -1.56 OCF / Share -1.56
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.66%
SBC-Adj. FCF -47.06 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -39.74 M -39.43 M -32.54 M -33.64 M -23.05 M
EPS (Diluted) -3.38 -5.97 — -0.23 —
Gross Profit — — — — —
Operating Income -38.53 M -42.00 M -36.73 M -33.32 M -23.53 M
EBITDA — — — — —
R&D Expenses 9.16 M 11.91 M 14.82 M 17.66 M 12.24 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 49,750.0 — — 10,839.0 10,839.0
Income Tax 1.06 M 576,000.0 576,000.0 576,000.0 1,233.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 130.94 M 116.65 M 103.61 M 114.00 M 142.43 M
Total Liabilities 53.41 M 42.55 M 12.18 M 10.57 M 9.65 M
Shareholders' Equity 67.55 M 70.08 M 90.83 M 102.83 M 132.18 M
Total Debt — — — — —
Cash & Equivalents 4.25 M 3.25 M 26.48 M 41.71 M 70.07 M
Current Assets 27.93 M 14.22 M 34.37 M 44.56 M 72.81 M
Current Liabilities 44.91 M 35.81 M 5.78 M 4.53 M 3.98 M